Park Borae G, Park Chan-Jeoung, Jang Seongsoo, Chi Hyun-Sook, Kim Dae-Young, Lee Jung-Hee, Lee Je-Hwan, Lee Kyoo-Hyung
Department of Laboratory Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Department of Laboratory Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea.
Leuk Res. 2015 Dec;39(12):1334-41. doi: 10.1016/j.leukres.2015.09.010. Epub 2015 Sep 10.
The reconstitution of different immunocyte subsets after hematopoietic stem cell transplantation (HSCT), follows different timelines. We prospectively investigated changes in lymphocyte subsets after HSCT and their associations with primary diagnosis, conditioning regimen, and HSCT type in event-free patients. A total of 95 patients (48 with acute myeloid leukemia, 22 with acute lymphoid leukemia, and 25 with myelodysplastic syndrome) who underwent allogeneic HSCT (34 sibling matched, 37 unrelated matched, and 24 haploidentical HSCT) but did not experience any events such as relapse or death were enrolled in this study. Lymphocyte subpopulations (T cells, helper/inducer T cells, cytotoxic/suppressor T cells, memory T cells, regulatory T cells, natural killer (NK) cells, NK-T cells, and B cells) were quantified by flow cytometry of peripheral blood from recipients 7 days before and 1, 2, 3, 6, and 12 months after HSCT. Leukocyte counts recovered within 1 month after HSCT. However, the number of T and B lymphocytes recovered at 2 months after HSCT. NK cell counts recovered shortly after haploidentical HSCT. However, T lymphocytes and their subpopulations showed delayed recovery after haploidentical HSCT. Lymphocyte subsets showed different sequential patterns according to HSCT type but no differences were seen according to primary diagnosis or conditioning regimen.
造血干细胞移植(HSCT)后不同免疫细胞亚群的重建遵循不同的时间线。我们前瞻性地研究了HSCT后淋巴细胞亚群的变化及其与无事件患者的初始诊断、预处理方案和HSCT类型的关联。本研究纳入了95例接受异基因HSCT(34例同胞全合、37例无关全合和24例单倍体相合HSCT)但未经历任何复发或死亡等事件的患者,其中48例为急性髓系白血病,22例为急性淋巴细胞白血病,25例为骨髓增生异常综合征。通过对HSCT前7天以及HSCT后1、2、3、6和12个月受者外周血进行流式细胞术,对淋巴细胞亚群(T细胞、辅助/诱导性T细胞、细胞毒性/抑制性T细胞、记忆T细胞、调节性T细胞、自然杀伤(NK)细胞、NK-T细胞和B细胞)进行定量分析。HSCT后1个月内白细胞计数恢复。然而,T淋巴细胞和B淋巴细胞数量在HSCT后2个月恢复。单倍体相合HSCT后NK细胞计数很快恢复。然而,单倍体相合HSCT后T淋巴细胞及其亚群恢复延迟。淋巴细胞亚群根据HSCT类型呈现不同的顺序模式,但根据初始诊断或预处理方案未观察到差异。